Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

Abeer F Alharbi,Robert A. Kratzke,Jonathan D’Cunha,Michael A. Maddaus,Kinjal Sanghavi,Mark N. Kirstein

Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

2019

Abeer F Alharbi
Robert A. Kratzke
Jonathan D’Cunha
Michael A. Maddaus
Kinjal Sanghavi
Mark N. Kirstein

Purpose We investigated the safety, pharmacokinetics, and efficacy of gemcitabine administered via bronchial artery infusion (BAI) and IV infusion in advanced NSCLC patients.

Keywords:

IV Infusion
Metabolite
Pharmacology
Gemcitabine
Pharmacokinetics
Medicine
Bronchial artery
Cmax
Gastroenterology
Internal medicine
Nausea
Toxicity
Active metabolite
Vomiting

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations